| 產品詳情 |
| Edit |   |
|---|
| Product Name | GSK 2606414 |
|---|
| Description | Potent and selective protein kinase R-like ER kinase (PERK) inhibitor (IC50 = 0.4 nM). Exhibits >1000-fold selectivity for PERK over HR1 and PKR. Inhibits thapsigargin-induced PERK phosphorylation in lung carcinoma A549 cells. Attenuates subcutaneous pancreatic human tumor xenograft growth in mice. Orally bioavailable. Purity 99%. MW (observed): 451.44 |
|---|
| Size | 10 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 1-[5-(4-Amino-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl]-2,3-dihydro-1H-indol-1-yl]-2-[3-(trifluoromethyl)phenyl]ethanone |
|---|
| Gene, Accession, CAS # | CAS: 1337531-36-8 |
|---|
| Catalog # | 5107/10 |
|---|
| Price | |
|---|
| Order / More Info | GSK 2606414 from TOCRIS BIOSCIENCE
|
|---|
| Product Specific References | PubMed: 29358734 |
|---|
| 產品資料 |
|
|